Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: A randomized, double-blind, placebo-controlled multicenter trial

Endoscopy

Volumn 40, Issue 8, 2008, Pages 631-636

  Beauchant, M ^a   Ingrand, P ^b   Favriel, J M ^c   Dupuychaffray, J P ^d   Capony, P ^d   Moindrot, H ^e   Barthet, M ^f   Escourrou, J ^g   Plane, C ^h   Barrioz, T ^a   Lacoste, L ^a   Ingrand, I ^b  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b Institute of Public Health   (France)

^c Hopital Manchester Centre Hospitalier de Charleville Mezieres   (France)

^d Gastroenterology Unit   (France)

^e Gastroenterology Unit   (France)

^f HÔPITAL NORD   (France)

^g CHU RANGUEIL   (France)

^h Gastroenterology Unit   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; GLYCERYL TRINITRATE; PLACEBO; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; ASPIRATION PNEUMONIA; BILE DUCT OBSTRUCTION; BLEEDING; BLOOD PRESSURE; BOLUS INJECTION; CHOLECYSTITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION ROUTE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INFUSION; DRUG WITHDRAWAL; DUODENUM PERFORATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GALLSTONE; HEADACHE; HEART RATE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VATER PAPILLA STENOSIS;

ABDOMINAL PAIN; ADULT; AGED; AMYLASES; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LIPASE; LOGISTIC MODELS; MALE; MIDDLE AGED; NITROGLYCERIN; PAIN MEASUREMENT; PANCREATITIS; PLACEBOS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 49749115677     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1077362     Document Type: Article

References (26)

1. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004; 59: 845-864
2. Singh P, Das A, Isenberg G et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004; 60: 544-550
3. Slivka A, Chuttani R, Carr-locke DL et al. Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J Clin Invest 1994; 94: 1792-1798
4. Sand J, Arvola P, Jäntti V et al. The inhibitory role of nitric oxide in the control of porcine and human sphincter of Oddi activity. Gut 1997; 41: 375-380
5. Staritz M, Poralla T, Ewe K et al. Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut 1985; 26: 194-1977
6. Coelho JCU, Wiederkehr JC. Motility of Oddi's sphincter: recent developments and clinical applications. Am J Surg 1996; 172: 48-51
7. Guelrud M, Mendoza S, Rossiter G et al. Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dysidnesia. Gastroenterology 1988; 95: 1050-1055
8. Khuroo MS, Zargar SA, Yattoo GN. Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, crossover trial. Br J Clin Pharmacol 1992; 33: 477-485
9. Staritz M, Poraila T, Dormeyer HH et al. Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation. Gastroenterology 1985; 88: 1807-1811
10. Bar-Meir S, Halpern Z Bardan E. Nitrate therapy in a patient with papillary dysfunction. Am J Gastroenterol 1983; 78: 94-95
11. Tzovaras G, Rowlands BJ. Diagnosis and treatment of sphincter of Oddi dysfunction. Br J Surg 1998; 85: 588-595
12. Kaffes AJ, Bourke MJ, Ding S et al. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006; 64: 351-357
13. Moreto M, Zaballa M, Casado I et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 2003; 57: 1-7
14. Sudhindran S, Bromwich E, Edwards PR. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001; 88: 1178-1182
15. Sherman S, Hawes RH, Troiano FP et al. Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter. Gastrointest Endosc 1992; 38: 347-350
16. Lehman GA, Sherman S. Sphincter of Oddi dysfunction. Int J Pancreatol 1996; 20: 11-25
17. Thomson IR, Mutch WAC, Culligan JD. Failure of intravenous nitroglycerin to prevent intraoperative myocardial ischemia during fentanylpancuronium anesthesia. Anesthesiology 1984; 61: 385-393
18. Coriat P. Daloz M, Bousseau D et al. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous nitroglycerin. Anesthesiology 1984; 61: 193-196
19. Cotton PB, Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastroentest Endosc 1991; 37: 383-393
20. Andriulli A Leandro G, Federici T et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007; 65: 624-632
21. Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004; 59: 8-14
22. Bergman JJ, Rauws EA, Fockens P et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones. Lancet 1997; 349: 1124-1129
23. De Weerth A, Seitz U, Zhong Y et al. Primary precutting versus conventional over-the-wire sphincterotomy for bile duct access: a prospective randomized study. Endoscopy 2006; 38: 1235-1240
24. Devière J, Le Moine O, Van Laetem JL et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505
25. Dumot JA, Conwell DL, Zuccaro G et al. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 2001; 96: 2098-2102
26. Kapetanos D, Kohozidis G, Christodoulou D et al. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis. Gastrointest Endosc 2007; 66: 513-518